» Vonoprazan News

Vonoprazan

Torrent pharma inks licensing pact with Takeda to commercialise GERD drug

Torrent pharma inks licensing pact with Takeda to commercialise GERD drug

Wed, Jun 05, 2024

Vonoprozan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders gastroesophageal reflux disease.

More >

TRENDING NOW

Compounding Returns: Rs 5,000 monthly SIP investment for 30 years vs Rs 17,500 monthly SIP for 20 years? Which can give higher return? Know here

Compounding Returns: Rs 5,000 monthly SIP investment for 30 years vs Rs 17,500 monthly SIP for 20 years? Which can give higher return? Know here

Latest FD Interest Rates: What SBI, PNB, HDFC Bank, ICICI Bank and other banks are offering in 3-year fixed deposit schemes

Latest FD Interest Rates: What SBI, PNB, HDFC Bank, ICICI Bank and other banks are offering in 3-year fixed deposit schemes

SBI Senior Citizen FD Interest Rates: Know how Rs 5 lakh, Rs 10 lakh, and Rs 15 lakh investments will give in maturity in Amrit Vrishti, 1-, 3-, and 5-year fixed deposit schemes

SBI Senior Citizen FD Interest Rates: Know how Rs 5 lakh, Rs 10 lakh, and Rs 15 lakh investments will give in maturity in Amrit Vrishti, 1-, 3-, and 5-year fixed deposit schemes

Top 7 Large and Mid Cap Mutual Funds With Highest SIP Returns in 10 Years: No. 1 fund has converted Rs 12,500 monthly investment into Rs 44,69,845

Top 7 Large and Mid Cap Mutual Funds With Highest SIP Returns in 10 Years: No. 1 fund has converted Rs 12,500 monthly investment into Rs 44,69,845

Analysts see major upside potential in these 5 Tata Group stocks

Analysts see major upside potential in these 5 Tata Group stocks

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x